Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
300760
Rang in Aktien
#765
Operating on a global scale, Shenzhen Mindray Bio-Medical Electronics Co., Ltd.... Operating on a global scale, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. specializes in providing a comprehensive range of medical devices and innovative healthcare solutions. Its extensive portfolio encompasses several key segments. Within patient monitoring and life support, the company manufactures crucial equipment such as patient monitoring systems, electrocardiographs, defibrillators, anesthesia machines, ventilators, infusion pumps, surgical lights, operating tables, medical supply units, and endoscopes, along with associated accessories. This segment also delivers integrated solutions for emergency care, peri-operative management, critical care, and medical IT systems. For in-vitro diagnostics, Mindray offers sophisticated products including hematology and chemistry analyzers and their reagents, chemiluminescence immunoassay products, hemoglobin systems, flow cytometry instruments, and microplate readers and washers. These are further supported by solutions tailored for coagulation, urinalysis, and microbiology. The company additionally produces advanced medical imaging systems, covering both ultrasound and radiology products, and supplies a dedicated line of veterinary products. Founded in 1991, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. maintains its primary operational base in Shenzhen, People's Republic of China.
Aktienkurs
$25.62
Marktkapitalisierung
$31.04B
Veränderung (1 Tag)
0.58%
Veränderung (1 Jahr)
-17.10%
Land
CN
Handel Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760)
Kategorie
Healthcare
Kursverlauf für Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760)
Höchster Schlusskurs: $24.22 am 2026-10-01
Niedrigster Schlusskurs: $12.94 am 2018-10-01
Niedrigster Schlusskurs: $12.94 am 2018-10-01
Kursverlauf der Aktie von Shenzhen Mindray Bio-Medical Electronics Co., Ltd. von 2018 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2026 (TTM) | -11.60% |
| 2025 | -20.41% |
| 2024 | -13.18% |
| 2023 | -9.79% |
| 2022 | -21.23% |
| 2021 | 0.15% |
| 2020 | 123.42% |
| 2019 | 60.82% |
| 2018 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $102.28 | -20.07% |
US
|
|
| $95.91 | 0.01% |
IE
|
|
| $305.79 | -21.26% |
US
|
|
| $45.76 | -55.94% |
US
|
|
| $47.05 | -17.88% |
DE
|
